ES2179093T3 - Inhibidores de la prolilendopeptidasa. - Google Patents
Inhibidores de la prolilendopeptidasa.Info
- Publication number
- ES2179093T3 ES2179093T3 ES95901820T ES95901820T ES2179093T3 ES 2179093 T3 ES2179093 T3 ES 2179093T3 ES 95901820 T ES95901820 T ES 95901820T ES 95901820 T ES95901820 T ES 95901820T ES 2179093 T3 ES2179093 T3 ES 2179093T3
- Authority
- ES
- Spain
- Prior art keywords
- inhibitors
- compounds
- formula
- present
- prolilendopeptidasa
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 208000000044 Amnesia Diseases 0.000 abstract 1
- 208000031091 Amnestic disease Diseases 0.000 abstract 1
- 208000026139 Memory disease Diseases 0.000 abstract 1
- 102000056251 Prolyl Oligopeptidases Human genes 0.000 abstract 1
- 101710178372 Prolyl endopeptidase Proteins 0.000 abstract 1
- 230000006986 amnesia Effects 0.000 abstract 1
- 230000006993 memory improvement Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16110693A | 1993-12-02 | 1993-12-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2179093T3 true ES2179093T3 (es) | 2003-01-16 |
Family
ID=22579844
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES95901820T Expired - Lifetime ES2179093T3 (es) | 1993-12-02 | 1994-11-08 | Inhibidores de la prolilendopeptidasa. |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US5661167A (enExample) |
| EP (1) | EP0731788B1 (enExample) |
| JP (1) | JPH09506090A (enExample) |
| KR (1) | KR100341982B1 (enExample) |
| CN (1) | CN1136806A (enExample) |
| AT (1) | ATE223894T1 (enExample) |
| AU (1) | AU684861B2 (enExample) |
| CA (1) | CA2177821C (enExample) |
| DE (1) | DE69431359T2 (enExample) |
| DK (1) | DK0731788T3 (enExample) |
| ES (1) | ES2179093T3 (enExample) |
| HU (1) | HUT74687A (enExample) |
| IL (1) | IL111775A (enExample) |
| NO (1) | NO962238L (enExample) |
| NZ (1) | NZ276600A (enExample) |
| PT (1) | PT731788E (enExample) |
| TW (1) | TW280818B (enExample) |
| WO (1) | WO1995015310A1 (enExample) |
| ZA (1) | ZA949302B (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5859031A (en) * | 1995-06-07 | 1999-01-12 | Gpi Nil Holdings, Inc. | Small molecule inhibitors of rotamase enzyme activity |
| EP1620091B1 (en) | 2003-05-05 | 2010-03-31 | Probiodrug AG | Inhibitors of glutaminyl cyclase |
| WO2006058720A2 (en) | 2003-11-03 | 2006-06-08 | Probiodrug Ag | Novel compounds for the treatment of neurological disorders |
| AU2004290499C1 (en) | 2003-11-03 | 2011-02-24 | Probiodrug Ag | Combinations useful for the treatment of neuronal disorders |
| WO2005075436A2 (en) | 2004-02-05 | 2005-08-18 | Probiodrug Ag | Novel inhibitors of glutaminyl cyclase |
| US8278345B2 (en) | 2006-11-09 | 2012-10-02 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
| ATE554085T1 (de) | 2006-11-30 | 2012-05-15 | Probiodrug Ag | Neue inhibitoren von glutaminylcyclase |
| JP5930573B2 (ja) | 2007-03-01 | 2016-06-15 | プロビオドルグ エージー | グルタミニルシクラーゼ阻害剤の新規使用 |
| WO2008128985A1 (en) | 2007-04-18 | 2008-10-30 | Probiodrug Ag | Thiourea derivatives as glutaminyl cyclase inhibitors |
| WO2008144748A1 (en) * | 2007-05-21 | 2008-11-27 | The Uab Research Foundation | Prolyl endopeptidase inhibitors for reducing or preventing neutrophilic inflammation |
| PL2475428T3 (pl) | 2009-09-11 | 2015-12-31 | Probiodrug Ag | Pochodne heterocykliczne jako inhibitory cyklazy glutaminowej |
| ES2586231T3 (es) | 2010-03-03 | 2016-10-13 | Probiodrug Ag | Inhibidores de glutaminil ciclasa |
| MX2012010470A (es) | 2010-03-10 | 2012-10-09 | Probiodrug Ag | Inhibidores heterociclicos d ciclasa de glutaminilo (qc, ec .3 2. 5). |
| US8541596B2 (en) | 2010-04-21 | 2013-09-24 | Probiodrug Ag | Inhibitors |
| EP2686313B1 (en) | 2011-03-16 | 2016-02-03 | Probiodrug AG | Benzimidazole derivatives as inhibitors of glutaminyl cyclase |
| WO2015116590A1 (en) | 2014-01-28 | 2015-08-06 | Spirit Global Energy Solutions, Inc. | Down-hole gas and solids separator utilized in production hydrocarbons |
| PL3461819T3 (pl) | 2017-09-29 | 2020-11-30 | Probiodrug Ag | Inhibitory cyklazy glutaminylowej |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4518528A (en) * | 1983-05-19 | 1985-05-21 | Rasnick David W | α Amino fluoro ketones |
| ZA86746B (en) * | 1985-02-04 | 1986-09-24 | Merrell Dow Pharma | Novel peptidase inhibitors |
| DE3712365A1 (de) * | 1987-04-11 | 1988-10-27 | Hoechst Ag | Neue 2-acylpyrrolidin-derivate, verfahren zu ihrer herstellung, sie enthaltende mittel sowie deren verwendung |
| US4855303A (en) * | 1987-07-01 | 1989-08-08 | Pfizer Inc. | Fluorine containing renin inhibitors |
| JPH0662591B2 (ja) * | 1988-12-14 | 1994-08-17 | 株式会社ヤクルト本社 | 新規なチオプロリン誘導体 |
| US5118811A (en) * | 1989-04-13 | 1992-06-02 | Japan Tobacco Inc. | Amino acid derivatives possessing prolyl endopeptidase-inhibitory activities |
-
1994
- 1994-11-08 AU AU10917/95A patent/AU684861B2/en not_active Ceased
- 1994-11-08 ES ES95901820T patent/ES2179093T3/es not_active Expired - Lifetime
- 1994-11-08 KR KR1019960702894A patent/KR100341982B1/ko not_active Expired - Fee Related
- 1994-11-08 CA CA002177821A patent/CA2177821C/en not_active Expired - Fee Related
- 1994-11-08 PT PT95901820T patent/PT731788E/pt unknown
- 1994-11-08 HU HU9601472A patent/HUT74687A/hu unknown
- 1994-11-08 WO PCT/US1994/012865 patent/WO1995015310A1/en not_active Ceased
- 1994-11-08 DE DE69431359T patent/DE69431359T2/de not_active Expired - Fee Related
- 1994-11-08 JP JP7515618A patent/JPH09506090A/ja not_active Ceased
- 1994-11-08 AT AT95901820T patent/ATE223894T1/de not_active IP Right Cessation
- 1994-11-08 CN CN94194374A patent/CN1136806A/zh active Pending
- 1994-11-08 NZ NZ276600A patent/NZ276600A/en unknown
- 1994-11-08 EP EP95901820A patent/EP0731788B1/en not_active Expired - Lifetime
- 1994-11-08 DK DK95901820T patent/DK0731788T3/da active
- 1994-11-23 ZA ZA949302A patent/ZA949302B/xx unknown
- 1994-11-24 TW TW083110932A patent/TW280818B/zh active
- 1994-11-27 IL IL111775A patent/IL111775A/en not_active IP Right Cessation
-
1996
- 1996-05-31 NO NO962238A patent/NO962238L/no not_active Application Discontinuation
- 1996-12-02 US US08/759,323 patent/US5661167A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| IL111775A (en) | 1998-06-15 |
| EP0731788B1 (en) | 2002-09-11 |
| ATE223894T1 (de) | 2002-09-15 |
| EP0731788A1 (en) | 1996-09-18 |
| CA2177821C (en) | 2000-03-28 |
| DK0731788T3 (da) | 2003-01-20 |
| DE69431359T2 (de) | 2003-07-31 |
| AU1091795A (en) | 1995-06-19 |
| IL111775A0 (en) | 1995-01-24 |
| WO1995015310A1 (en) | 1995-06-08 |
| US5661167A (en) | 1997-08-26 |
| NZ276600A (en) | 1997-09-22 |
| KR100341982B1 (ko) | 2002-11-30 |
| ZA949302B (en) | 1995-08-07 |
| NO962238D0 (no) | 1996-05-31 |
| HU9601472D0 (en) | 1996-07-29 |
| CA2177821A1 (en) | 1995-06-08 |
| CN1136806A (zh) | 1996-11-27 |
| JPH09506090A (ja) | 1997-06-17 |
| TW280818B (enExample) | 1996-07-11 |
| AU684861B2 (en) | 1998-01-08 |
| DE69431359D1 (de) | 2002-10-17 |
| NO962238L (no) | 1996-05-31 |
| HUT74687A (en) | 1997-01-28 |
| PT731788E (pt) | 2003-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT731788E (pt) | Inibidores de prolil endopeptidase | |
| BG103485A (en) | Ketobanzamides as calpain inhibitors | |
| CA2244785A1 (en) | Pentafluorobenzenesulfonamides and analogs | |
| ATE172968T1 (de) | Substituierte azadioxacycloalkene und ihre verwendung als fungizide | |
| TR200101398T2 (tr) | Pirolidin türevleri-CCR-3 reseptörü antagonistleri. | |
| ATE148130T1 (de) | Typ-iv-dipeptidyl-aminopeptidase-inhibitoren | |
| TR200003056T2 (tr) | Heterosiklik olarak ikame edilmiş amidler, üretimi ve kullanımı | |
| MD1838F2 (en) | 5,6-dichlorbenzimidazole derivatives, process for obtaining thereof, pharmaceutical composition and method of treatment or prevention of herpetic viral infections | |
| DK0830350T3 (da) | Hidtil ukendte N-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1H-benzo[B][1,5]diazepin-3-yl)acetamider | |
| MX9804588A (es) | Uso de composiciones que comprenden blanqueador de halogeno para suavidad mejorada a la piel. | |
| EA200200510A1 (ru) | 4-карбоксиамино-2-этил-1,2,3,4-тетрагидрохинолин в кристаллической форме как ингибитор сетр | |
| DE69516128D1 (de) | Mercaptoacetylamid-1,3,4,5-tetrahydrobenzo(c)azepin-3-ein disulfidderivate als enkephalinase und ace inhibitoren | |
| DE69405862D1 (de) | Substituierte pyrrolidin-3-alkyl-piperidine verwendbar als tachykinin-antagonisten | |
| CA2266759A1 (en) | 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase | |
| TR200101979T2 (tr) | Antidepresyon tedavisi için 5HT1 antagonistleri. | |
| DE69624308D1 (de) | Bernsteinsäurederivate als abbaubare Chelatbildner, ihre Verwendungen und Zusammensetzungen | |
| TR199901416T2 (xx) | Heterosiklik karbonikasit t�revleri. | |
| TR199800210T2 (xx) | Didepsipeptid temelli endoparazitisid kompozisyonlar, yeni didepsipeptidler ve bunlar�n �retimi i�in i�lemler. | |
| ID27440A (id) | Proses untuk menyiapkan penengah-penengah | |
| PL322969A1 (en) | Substituted phenylamidines, pharmaceutic compositions containing theses compounds and method of obtaining them | |
| NO306714B1 (no) | Krystallinsk, polymorf form av (S,S,S)-N-(1-[2-karboksy-3-(N2-mesyllysylamino)propyl]-1-cyklopentylkarbonyl)-tyrosin | |
| BR9407232A (pt) | Compostos de tiocarbamoíla | |
| KR960700223A (ko) | C-치환 디에틸렌 트리아민의 제조 방법(Process for the Production of C-Substituted Diethylenetriamines) | |
| ATE364594T1 (de) | (4-acylaminopiperidin-1-yl)acetamide als neurokininantagonisten | |
| DK0815109T3 (da) | Fremgangsmåde til fremstilling af estere af anhydroecgonin |